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AbstrACt
Introduction The efficacy of both intravenous treatment 
(IVT) and endovascular treatment (EVT) for patients with acute 
ischaemic stroke strongly declines over time. Only a subset of 
patients with ischaemic stroke caused by an intracranial large 
vessel occlusion (LVO) in the anterior circulation can benefit 
from EVT. Several prehospital stroke scales were developed 
to identify patients that are likely to have an LVO, which could 
allow for direct transportation of EVT eligible patients to an 
endovascular-capable centre without delaying IVT for the other 
patients. We aim to prospectively validate these prehospital 
stroke scales simultaneously to assess their accuracy in 
predicting LVO in the prehospital setting.
Methods and analysis Prehospital triage of patients with 
suspected stroke symptoms (PRESTO) is a prospective 
multicentre observational cohort study in the southwest of the 
Netherlands including adult patients with suspected stroke in 
the ambulance. The paramedic will assess a combination of 
items from five prehospital stroke scales, without changing 
the normal workflow. Primary outcome is the clinical diagnosis 
of an acute ischaemic stroke with an intracranial LVO in the 
anterior circulation. Additional hospital data concerning the 
diagnosis and provided treatment will be collected by chart 
review. Logistic regression analysis will be performed, and 
performance of the prehospital stroke scales will be expressed 
as sensitivity, specificity and area under the receiver operator 
curve.
Ethics and dissemination The Institutional Review Board of 
the Erasmus MC University Medical Centre has reviewed the 
study protocol and confirmed that the Dutch Medical Research 
Involving Human Subjects Act (WMO) is not applicable. The 
findings of this study will be disseminated widely through 
peer-reviewed publications and conference presentations. The 
best performing scale, or the simplest scale in case of clinical 
equipoise, will be integrated in a decision model with other 
clinical characteristics and real-life driving times to improve 
prehospital triage of suspected stroke patients.
trial registration number NTR7595.
IntroduCtIon
Rapid treatment with intravenous treat-
ment (IVT) is effective for patients with an 
ischaemic stroke of <4.5 hours after onset.1 2 
However, the effect of IVT is limited for isch-
aemic stroke caused by an intracranial large 
vessel occlusion (LVO) in the anterior 
circulation, which accounts for approxi-
mately 30% of the patients.3 These patients 
can benefit from endovascular treatment 
(EVT), preferably started within 6 hours after 
onset of symptoms, but this treatment can 
only be performed in specialised interven-
tion centres.4 The effect of both treatments 
strongly declines over time.5–7 In current clin-
ical practice, most suspected stroke patients 
are transported by ambulance to the nearest 
hospital for immediate treatment with IVT. 
Patients can subsequently be transferred to 
an endovascular capable centre, if eligible 
for EVT. This is one of the main causes of 
strengths and limitations of this study
 ► Prospective simultaneous validation of several pre-
hospital stroke scales allows for direct comparison 
of their accuracy.
 ► In contrast to previous studies based on in-hospital 
assessment by experienced physicians, assessment 
of the prehospital stroke scales will be performed by 
paramedics in daily clinical practice.
 ► The results of this study will provide unique insight 
in the characteristics of an unselected group of 
patients with suspected stroke in the prehospital 
setting.
 ► The best performing scale will be integrated in a 
prehospital decision tool with other clinical charac-
teristics and real-life driving times to select those 
patients that benefit from direct transportation to an 
endovascular-capable centre.
 ► Performance will be measured with the area under 
the receiver operator curve, which does not always 
relate directly to the clinical usefulness of these 
scales.
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treatment delay and is associated with worse functional 
outcomes after EVT.8 9 
Several prehospital stroke scales were developed to iden-
tify patients that are likely to have an LVO, which could 
allow for direct transportation of EVT eligible patients 
to an endovascular-capable centre without delaying 
IVT for the other patients.10 11 Most of these scales were 
derived from the National Institute of Health Stroke 
Severity (NIHSS) score, and external validation was often 
attempted by retrospective assessment of the items based 
on the NIHSS score completed by the treating physician 
at the emergency department.12–14 The results of existing 
prehospital validation studies are limited due to small 
sample sizes, selected populations or the exclusion of 
stroke mimics.15–18 Further prospective validation is there-
fore required to assess and compare the accuracy of these 
scales when used by emergency medical services (EMS) 
personnel in a broad population of suspected stroke 
patients under circumstances that reflect usual care.
objective
The primary objective of this study is to prospectively vali-
date several prehospital stroke scales simultaneously to 
assess their accuracy in predicting the likelihood of isch-
aemic stroke caused by an intracranial LVO in the prehos-
pital setting.
MEthods And AnAlysIs
study design
Prehospital triage of patients with suspected stroke 
symptoms (PRESTO) is a prospective multicentre obser-
vational cohort study. Patients will be recruited in the 
ambulance, and a combination of items from different 
prehospital stroke scales will be assessed by the para-
medic. The normal workflow will not be affected, and 
there is no intervention. Additional hospital data will be 
collected by chart review. Routinely performed neuroim-
aging will be collected and centrally assessed. Follow-up 
will only be performed in patients with a final diagnosis 
of ischaemic stroke.
study population
We will include patients in the southwest of the Nether-
lands, a region with approximately 2 million inhabitants. 
Participating paramedics have ample experience with the 
initial management of patients with acute neurological 
deficits, and they received additional training before the 
start of the study with regards to the study procedures 
and the use of the prehospital stroke scales. Additional 
to the prior training, an instruction video is available for 
all paramedics. Also, during the duration of the study, 
regular visits are paid to all ambulance stations to provide 
feedback and address uncertainty or questions of the 
paramedics. All adult patients with acute neurological 
deficit, defined as at least one point on the Face-Arm-
Speech-Test (FAST), and a suspected diagnosis of stroke 
by the paramedic, will be included. Patients with a blood 
glucose level below 2.5 mmol/L will be excluded.
Prehospital stroke scales
We choose five well known prehospital stroke scales 
to validate: the Los Angeles Motor Scale (LAMS),19 20 
the Rapid Arterial oCclusion Evaluation (RACE),18 the 
Cincinnati Stroke Triage Assessment Tool (C-STAT),21 
the Prehospital Acute Stroke Severity scale (PASS)22 and 
the Gaze-Face-Arm-Speech-Test (G-FAST).23 These scales 
have many similarities in the items that are being used, 
but there are differences in the scoring systems and the 
degree of complexity of these scores. In the PRESTO 
study, we will assess a combination of the items used in 
these five scales (table 1).
data collection
Eligible patients presenting with suspected stroke symp-
toms will be recruited in the ambulance. The items from 
the prehospital stroke scales will be assessed by the para-
medic and entered in a web-based database (LimeSurvey 
GmbH/Carsten Schmitz, https://www. limesurvey. org). 
The paramedic will also enter the transportation number 
(to link with EMS data and hospital data), the time of 
symptom onset or last known well (according to patient 
or bystander), the side of the hemiparesis (if applicable) 
and the presence of a known neurological deficit on the 
symptomatic side. Data concerning demographics, vital 
functions, general neurological examination and trans-
portation times will be collected from the EMS databases.
After arrival in the hospital, patients will receive the 
usual care. A non-contrast CT scan and additional imaging 
(eg, CT angiography (CTA), digital subtraction angiog-
raphy (DSA) and/or CT perfusion) can be performed 
as part of the regular workup of a suspected stroke. No 
additional imaging will be performed in the context of 
this study. Clinical data concerning the medical history, 
medication use, laboratory results, physical examination 
and diagnosis will be collected by chart review. All diag-
nostic neuroimaging data and radiology reports will be 
collected. If applicable, we will also collect information on 
the given treatment and corresponding treatment times 
(eg, the door-to-needle time, the door-to-groin time, the 
imaging-to-treatment time and the door-in-door-out time 
of transferred patients).
Follow-up will only be collected for patients with a 
final diagnosis of acute ischaemic stroke. We will use the 
outcome registration of the hospitals to collect length 
of hospital stay, discharge destination and the modified 
Rankin Scale (mRS) score after 90 days.
outcome measures
Primary outcome will be the clinical diagnosis of an acute 
ischaemic stroke with an intracranial LVO in the ante-
rior circulation, defined as an occlusion of the internal 
carotid artery, the middle cerebral artery segment M1 
or M2 or the anterior cerebral artery segment A1 or A2 
(assessed on CTA or DSA). Secondary outcome measures 
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Table 1 Overview of the items and corresponding scores used in the prehospital stroke scales
Item LAMS RACE C-STAT PASS G-FAST
Items collected 
in this study
Answering questions (age and current month)
  A. Correctly answers both questions 0 0 0
  B. Correctly answers one question 1* 1 1
  C. Does not correctly answer either question
Following commands (‘close your eyes, ‘make a fist’)
  A. Correctly performs both tasks 0† 0 0
  B. Correctly performs one task 1† 1* 1
  C. Does not correctly perform either task 2† 2
Head and gaze deviation
  A. Normal; able to follow pen or finger to both sides 0 0 0 0 0
  B. Gaze palsy or deviation (total or partial) 1 2 1 1 1
Facial palsy
  A. Normal and symmetrical movement 0 0 0 0
  B. Mild palsy (flattened nasolabial fold or minor 
asymmetry in smile)
1 1 1
  C. Moderate to severe palsy 1 2 2
Grip strength
  A. Normal grip strength 0 0
  B. Weak grip strength 1 1
  C. No grip possible 2 2
Motor function arm
  A. Normal 0 0 0 0 0 0
  B. Drift (minimal drift with closed eyes) 1 1 1
  C. Mild palsy (arm drifts down within 10 s) 1 1 1
  D. Severe palsy (not able to lift arm) 2 2 2
Motor function leg
  A. Normal 0 0
  B. Drift (minimal drift with closed eyes)
  C. Mild palsy (leg drifts down within 5 s) 1 1
  D. Severe palsy (not able to lift leg) 2 2
Language
  A. Normal speech 0 0
  B. Speech problems (dysarthria, language 
abnormality or unable to speak)
1 1
Agnosia
  A. Patient recognises his/her arm and the impairment 0‡ 0‡
  B. Does not recognises his/her arm or the 
impairment
1‡ 1‡
  C. Does not recognises his/her arm nor the 
impairment
2‡ 2‡
*Point if the patient answers at least one question incorrect and does not follow at least one command.
†Only scored if right hemiparesis ‡Only scored if left hemiparesis.
C-STAT, Cincinnati Stroke Triage Assessment Tool; G-FAST, Gaze-Face-Arm-Speech-Test; LAMS, Los Angeles Motor Scale; PASS,  
Prehospital Acute Stroke Severity scale; RACE, Rapid Arterial oCclusion Evaluation. 
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include the presence of an LVO in the posterior circula-
tion (vertebral artery or basilar artery), the final diagnosis 
at hospital discharge, the given treatment (IVT, EVT or 
both) and corresponding treatment times and the func-
tional outcome, measured with the 90-day mRS.
sample size calculation
At least 100 events (ie, intracranial LVOs) are required 
for the external validation of predictive models.24 25 The 
annual incidence of suspected ischaemic stroke within 
6 hours after onset of symptoms is estimated to be 50 per 
100 000 people, based on an earlier cohort study.14 In the 
catchment area of the participating EMS (approximately 
2 million inhabitants), this would imply 1000 patients 
every year presenting with stroke symptoms within the 
6-hour time window. Of these 1000 patients, approxi-
mately 15% are assumed to have an ischaemic stroke due 
to an LVO, 31% an ischaemic stroke without the presence 
of an LVO, 9% a transient ischaemic attack (TIA), 10% 
an intracerebral haemorrhage and 35% a stroke mimic.14 
To reach the required number of 100 stroke patients with 
an LVO, we will have to include at least (number of cases/
prevalence=100/0.15) 667 patients with stroke symptoms 
of <6 hours. To allow for a 5% loss of follow-up, we will 
aim for a sample size of 700 patients.
After inclusion of the first 500 patients, we will perform 
an interim analysis to calculate the percentage of LVO in 
our study population. If necessary, the required sample 
size will be adjusted based on this information. Although 
patients presenting after 6 hours will be included in the 
study, they will not count for the required sample size.
data analysis plan
After completion of the last inclusion, the data will be 
checked, and the database will be locked for statistical 
analyses. We will report the absolute numbers and percent-
ages of patients based on the final diagnosis (eg, isch-
aemic stroke, haemorrhagic stroke, TIA or stroke mimic) 
and, if applicable, the location of the intracranial LVO. 
For ischaemic stroke patients, we will report the given 
treatment (IVT, EVT or both) and corresponding treat-
ment times, the number of interhospital transfers and the 
functional outcome after 90 days. Missing values will be 
imputed with simple imputation based on the mean or 
mode (if <5% missing) or multiple imputations based on 
relevant covariates and outcome (if >5% missing).
The different prehospital stroke scales will be recon-
structed based on the items assessed in the ambulance 
(table 1). We will validate the prehospital stroke scales for 
patients presented within 6 hours after symptom onset 
using a logistic regression model with the presence of an 
LVO in the anterior circulation as outcome measure. We 
will analyse the scores both continuously and dichoto-
mised, based on the previously reported cut points in the 
original studies. Sensitivity and specificity of all cut points 
will be reported separately. The global performance of 
the prehospital stroke scales will be expressed as the area 
under the receiver operator curve.
Prespecified sensitivity analyses will be performed for 
patients that presented more than 6 hours after symptom 
onset for the separate occlusion locations and the pres-
ence of an LVO in the posterior circulation. We will also 
assess the original outcome definitions as defined in 
each prehospital stroke scale instead of our own primary 
outcome, and we will analyse the correlation between 
the prehospital stroke scales and the NIHSS assessed at 
the emergency department. Additional analyses will be 
performed to predict the probability of treatment with 
EVT based on the prehospital stroke scales and relevant 
factors in the medical history, medication use or vital 
signs.
Patient and public involvement
Patients and public were not involved in the development 
of the research questions or the design of this study. All 
study participants and every interested person in public 
will have the possibility to read regular project updates on 
the project website ( www. presto- studie. nl).
duration and current status of the study
The study was registered in The Netherlands Trial 
Register on 11 November 2018 under number NTR7595 ( 
www. trialregister. nl). The study started on 13 August 2018 
in the region Zuid-Holland Zuid and on 1 September 
2018 in the region Rotterdam-Rijnmond. Recruitment of 
patients is ongoing, and at the time of submission, April 
2019, 665 patients have been included in the study within 
6 hours of symptom onset. In anticipation of a formal 
interim analysis, first raw data analysis shows a prevalence 
of 8% LVO in our study population. Based on this infor-
mation, we increased our sample size to 1250 patients. 
With the current inclusion rate, we expect to reach the 
required sample size of 1250 patients by September 2019.
Ethics and dissemination
Ethical aspects and informed consent
This study will be conducted in accordance with the prin-
ciples of Good Clinical Practice, the Dutch Agreement 
on Medical Treatment Act (WGBO) and the European 
General Data Protection Regulation. The Institutional 
Review Board of the Erasmus MC University Medical 
Centre has reviewed the study protocol and confirmed 
that the Dutch Medical Research Involving Human 
Subjects Act (WMO) is not applicable.
Acquiring informed consent can be very challenging 
in the prehospital inclusion of suspected stroke patients. 
Many patients suffer from a language deficit, anosognosia, 
or other cognitive symptoms that impede an informed 
consent procedure, and often there is no (legal) repre-
sentative of the patient present in the prehospital setting. 
Furthermore, an adequate informed consent procedure 
takes time, which is not available in the prehospital 
setting. Sometimes a deferred consent procedure can 
be used, but in the context of the WGBO, this should 
be done by the treating physician. Since our unselected 
population of patients, including many stroke mimics, 
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will spread towards different directions after presentation 
in the hospital, a disproportionate number of healthcare 
providers from a variety of specialisms (eg, neurologists, 
emergency physicians, internists, cardiologists) should 
be involved in the research to enable a deferred consent 
procedure.
The extent of the effort by a large number of health-
care providers needed to obtain permission from the 
participating patients is disproportionate to the relatively 
limited sensitivity of the collected and linked personal 
data and the related limited intrusion to the personal 
privacy. We will therefore use an opt-out procedure in this 
study. The including paramedic will provide a leaflet with 
information about the study to the patient or their rela-
tives. In this leaflet, we will explain that some routinely 
collected data can be collected from the EMS databases 
and the hospital charts for further analysis. Patients or 
their relatives are offered the opportunity to object to the 
use of these data in this study. When a patient or relative 
objects to study participation, all data will be destroyed, 
and the patient will be excluded from the study.
dissemination plan
The main study results will be disseminated via publi-
cation in an international peer-reviewed journal and 
presentation at international conferences for stroke and 
emergency medicine experts. Representatives of the EMS 
providers and participating hospitals will be given the 
opportunity to comment on the manuscript and partic-
ipate as coauthor, following the recommendations of the 
International Committee of Journal Editors. We plan to 
disseminate the results of the planned secondary analyses 
in one or more separate papers.
The best performing scale or the simplest scale in case 
of clinical equipoise, will be integrated in a decision model 
with other clinical characteristics and real-life driving 
times.26 This model can be implemented in an online tool 
to improve prehospital triage of patients with suspected 
stroke symptoms without harming those patients that 
benefit from rapid IVT in the nearest hospital. Patients 
eligible for EVT will be directly transported to an endo-
vascular-capable centre, which will lead to an increased 
number of treated patients, reduced treatment times and 
improved patient outcomes. Moreover, avoiding unneces-
sary interhospital transfers will lead to more efficient use 
of EMS resources.
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